651 related articles for article (PubMed ID: 24079772)
1. Bioenergetics and mitochondrial dysfunction in aging: recent insights for a therapeutical approach.
Romano AD; Greco E; Vendemiale G; Serviddio G
Curr Pharm Des; 2014; 20(18):2978-92. PubMed ID: 24079772
[TBL] [Abstract][Full Text] [Related]
2. Reactive Oxygen Species and the Aging Eye: Specific Role of Metabolically Active Mitochondria in Maintaining Lens Function and in the Initiation of the Oxidation-Induced Maturity Onset Cataract--A Novel Platform of Mitochondria-Targeted Antioxidants With Broad Therapeutic Potential for Redox Regulation and Detoxification of Oxidants in Eye Diseases.
Babizhayev MA; Yegorov YE
Am J Ther; 2016; 23(1):e98-117. PubMed ID: 21048433
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial bioenergetics in aging.
Lenaz G; D'Aurelio M; Merlo Pich M; Genova ML; Ventura B; Bovina C; Formiggini G; Parenti Castelli G
Biochim Biophys Acta; 2000 Aug; 1459(2-3):397-404. PubMed ID: 11004456
[TBL] [Abstract][Full Text] [Related]
5. Metabolic reprogramming of human cells in response to oxidative stress: implications in the pathophysiology and therapy of mitochondrial diseases.
Wu YT; Wu SB; Wei YH
Curr Pharm Des; 2014; 20(35):5510-26. PubMed ID: 24606797
[TBL] [Abstract][Full Text] [Related]
6. Reconsidering the Role of Mitochondria in Aging.
Gonzalez-Freire M; de Cabo R; Bernier M; Sollott SJ; Fabbri E; Navas P; Ferrucci L
J Gerontol A Biol Sci Med Sci; 2015 Nov; 70(11):1334-42. PubMed ID: 25995290
[TBL] [Abstract][Full Text] [Related]
7. [Skeletal muscle aging and mitochondrial dysfunction: an update].
Faitg J; Reynaud O; Leduc-Gaudet JP; Gouspillou G
Med Sci (Paris); 2017 Nov; 33(11):955-962. PubMed ID: 29200393
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress, mitochondrial bioenergetics, and cardiolipin in aging.
Paradies G; Petrosillo G; Paradies V; Ruggiero FM
Free Radic Biol Med; 2010 May; 48(10):1286-95. PubMed ID: 20176101
[TBL] [Abstract][Full Text] [Related]
9. Phloretin ameliorates arsenic trioxide induced mitochondrial dysfunction in H9c2 cardiomyoblasts mediated via alterations in membrane permeability and ETC complexes.
Vineetha VP; Soumya RS; Raghu KG
Eur J Pharmacol; 2015 May; 754():162-72. PubMed ID: 25746422
[TBL] [Abstract][Full Text] [Related]
10. Mitochondria: a hub of redox activities and cellular distress control.
Kakkar P; Singh BK
Mol Cell Biochem; 2007 Nov; 305(1-2):235-53. PubMed ID: 17562131
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress and mitochondrial dysfunction in atherosclerosis: mitochondria-targeted antioxidants as potential therapy.
Victor VM; Apostolova N; Herance R; Hernandez-Mijares A; Rocha M
Curr Med Chem; 2009; 16(35):4654-67. PubMed ID: 19903143
[TBL] [Abstract][Full Text] [Related]
12. The role of oxidative damage in mitochondria during aging: a review.
Huang H; Manton KG
Front Biosci; 2004 May; 9():1100-17. PubMed ID: 14977532
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria, oxidative stress, and temporal lobe epilepsy.
Waldbaum S; Patel M
Epilepsy Res; 2010 Jan; 88(1):23-45. PubMed ID: 19850449
[TBL] [Abstract][Full Text] [Related]
14. Increased mitochondrial ROS formation by acetaminophen in human hepatic cells is associated with gene expression changes suggesting disruption of the mitochondrial electron transport chain.
Jiang J; Briedé JJ; Jennen DG; Van Summeren A; Saritas-Brauers K; Schaart G; Kleinjans JC; de Kok TM
Toxicol Lett; 2015 Apr; 234(2):139-50. PubMed ID: 25704631
[TBL] [Abstract][Full Text] [Related]
15. [Mitochondrial dysfunction as a promoting factor of senescence].
Ikawa M; Yoneda M
Nihon Rinsho; 2009 Jul; 67(7):1321-5. PubMed ID: 19591279
[TBL] [Abstract][Full Text] [Related]
16. Genipin ameliorates age-related insulin resistance through inhibiting hepatic oxidative stress and mitochondrial dysfunction.
Guan L; Feng H; Gong D; Zhao X; Cai L; Wu Q; Yuan B; Yang M; Zhao J; Zou Y
Exp Gerontol; 2013 Dec; 48(12):1387-94. PubMed ID: 24041487
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress and mitochondrial dysfunction in sepsis: a potential therapy with mitochondria-targeted antioxidants.
Víctor VM; Espulgues JV; Hernández-Mijares A; Rocha M
Infect Disord Drug Targets; 2009 Aug; 9(4):376-89. PubMed ID: 19689380
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Strategies for Mitochondrial Dysfunction and Oxidative Stress in Age-Related Metabolic Disorders.
Bhatti JS; Kumar S; Vijayan M; Bhatti GK; Reddy PH
Prog Mol Biol Transl Sci; 2017; 146():13-46. PubMed ID: 28253984
[TBL] [Abstract][Full Text] [Related]
19. Principles and therapeutic relevance for targeting mitochondria in aging and neurodegenerative diseases.
Serviddio G; Romano AD; Cassano T; Bellanti F; Altomare E; Vendemiale G
Curr Pharm Des; 2011; 17(20):2036-55. PubMed ID: 21718251
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
